Skip to main content

Human Recombinant Monoclonal SPIKE antibody. Suitable for ELISA, I-ELISA and reacts with Recombinant full length protein - SARS-CoV-2, Recombinant full length protein - SARS-CoV, Recombinant fragment - SARS-CoV-2 samples. Cited in 27 publications. Immunogen corresponding to Cell preparation containing SARS-CoV-2 Spike Glycoprotein S1 protein.

Isotype

IgG1

Host species

Human

Storage buffer

Preservative: 0.02% Proclin 300
Constituents: PBS

Form

Liquid

Clonality

Monoclonal

Immunogen

Cell preparation containing SARS-CoV-2 Spike Glycoprotein S1 protein. The exact immunogen used to generate this antibody is proprietary information.

Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Shipping To:
United States

Reactivity data

Select an application
Product promiseTestedExpectedPredictedNot recommended
ELISAI-ELISA
Recombinant fragment - SARS-CoV-2
Not recommended
Tested
Recombinant full length protein - SARS-CoV
Tested
Not recommended
Recombinant full length protein - SARS-CoV-2
Tested
Not recommended
SARS-CoV
Predicted
Predicted
SARS-CoV-2
Predicted
Predicted

Images

Tested
Tested

Species
Recombinant full length protein - SARS-CoV-2, Recombinant full length protein - SARS-CoV
Dilution info
-
Notes

-

Predicted
Predicted

Species
SARS-CoV, SARS-CoV-2
Dilution info
-
Notes

-

Not recommended
Not recommended

Species
Recombinant fragment - SARS-CoV-2
Dilution info
-
Notes

-

Tested
Tested

Species
Recombinant fragment - SARS-CoV-2
Dilution info
-
Notes

-

Predicted
Predicted

Species
SARS-CoV, SARS-CoV-2
Dilution info
-
Notes

-

Not recommended
Not recommended

Species
Recombinant full length protein - SARS-CoV-2, Recombinant full length protein - SARS-CoV
Dilution info
-
Notes

-

Target data

Recommended products

  1. Loading...
  2. Loading...
  3. Loading...
  4. Loading...

Human Recombinant Monoclonal SPIKE antibody. Suitable for ELISA, I-ELISA and reacts with Recombinant full length protein - SARS-CoV-2, Recombinant full length protein - SARS-CoV, Recombinant fragment - SARS-CoV-2 samples. Cited in 27 publications. Immunogen corresponding to Cell preparation containing SARS-CoV-2 Spike Glycoprotein S1 protein.

Key facts

Isotype

IgG1

Form

Liquid

Clonality

Monoclonal

Immunogen

Cell preparation containing SARS-CoV-2 Spike Glycoprotein S1 protein. The exact immunogen used to generate this antibody is proprietary information.

Clone number

CR3022

Purification technique

Affinity purification Protein A

Epitope

This antibody binds the amino acids 318-510 in the S1 domain of the SARS-CoV Spike protein as well as SARS-CoV-2 (COVID-19) Spike protein. The antibody also binds to P462L-substituted S318–510 fragments of the SARS spike protein. The binding epitope is only accessible in the "open" conformation of the spike protein (Joyce et al. 2020).

Light chain type

kappa

Concentration
Loading...

Storage

Shipped at conditions

Blue Ice

Appropriate short-term storage duration

1-2 weeks

Appropriate short-term storage conditions

+4°C

Appropriate long-term storage conditions

-20°C

Aliquoting information

Upon delivery aliquot

Storage information

Avoid freeze / thaw cycle

Notes

The original CR3022 antibody was generated by sequencing peripheral blood lymphocytes of a patient exposed to the SARS-CoV. This antibody was shown to neutralize SARS-COV in a concerted action with clone CR3014. Presence of both antibodies delivers a blocking action of the SARS-COV RBD-ACE2 interaction, by binding two distinct and functional epitopes (16796401).

CR3022 has been shown to bind with a high affinity to SARS-CoV2 (32416259, 32413276). Structural modelling has confirmed that CR3022 targets a conserved epitope between SARS-CoV and SARS-CoV2 in the RBD domain (32245784, 32065055). Precisely, this antibody binds to the 'open' conformation of the spike protein to the amino acids 318-510 in the S1 domain of the SARS-CoV as well as SARS-CoV-2 strains (32245784, Joyce et al. 2020). The antibody is also able to bind the P462L-substituted S318–510 fragments of the SARS spike protein. The binding epitope of clone CR3022 does not overlap with the ACE2 binding site of SARS-COV2 (32065055). Therefore whilst CR3022 can neutralise SARS-COV in in a concerted action with clone CR3014, CR3022 is not believed to independently neutralise SARS-COV2, based on in vitro studies (32226289, 32065055, 32383254, 32416259).

Recombinant Anti-SARS-CoV-2 Spike Glycoprotein S1 antibody (ab273073) is a Human IgG1 Recombinant version of CR3022 for research use only. CR3022 is also available as a chimeric rabbit antibody (ab273074).

Applications overview

Tick: Tested and Guaranteed to work X: Will not work —: No data

ab273073 was developed to have a human IgG1 isotype.
Other isotypes of clone CR3022 available:
ab278112 – human IgA
ab278111 – human IgM
ab273074 – rabbit IgG
ab273886 – rat IgG2a

Product promise

We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.

In the unlikely event of one of our products not working as expected, you are covered by our product promise.

Full details and terms and conditions can be found here:
Terms & Conditions.

Downloads

Product protocols

For this product, it's our understanding that no specific protocols are required. You can:

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com

There was a problem

We can’t download that datasheet. Please try again. If you need help, contact our Customer Services team at technical@abcam.com